Status
Conditions
Treatments
About
This research study is a randomized controlled trial that will observe changes in microbiome activity, changes in chemotherapy toxicity, and any changes in treatment outcomes between two groups of participants undergoing chemotherapy with either early-stage or metastatic colorectal cancer.
The names of the study groups involved in this study are:
Full description
This research study is a single-center, two-armed, randomized controlled trial that will observe changes in microbiome activity, changes in chemotherapy toxicity, and any changes in treatment outcomes between two groups of participants undergoing chemotherapy with either early-stage or metastatic colorectal cancer. Participants will be randomly assigned to one of two groups: Group A: Exercise group (EXE) vs. Group B: Waitlist control group (WC). Randomization means that a participant will be placed into one of the study groups by chance.
The research study procedures include screening for eligibility, blood tests, stool samples, and survey questionnaires.
Participation in this research study will last up to 6 months.
It is expected that about 84 people will take part in this research study.
The American Cancer Society is providing funding for this research study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
84 participants in 2 patient groups
Loading...
Central trial contact
Christina Dieli-Conwright, MPH, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal